
Highlights
•Plasma TMAO levels are elevated in type 2 diabetic patients
•Levels of the TMAO-producing enzyme FMO3 in adipose tissue correlate with obesity
•Pharmacologic and genetic inhibition of Fmo3 stimulates white adipose tissue beiging
•Inhibition of Fmo3 promotes resistance to obesity
Cleveland Clinic researchers showed that blocking a specific intestinal microbial pathway can prevent obesity and insulin resistance, as well as cause fat tissue to become more metabolically active. The team, led by J. Mark Brown, Ph.D...
Read More
Recent Comments